Skip to main content

Advertisement

Log in

Idiopathic hypereosinophilic syndrome presenting with hepatitis and achalasia

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Idiopathic hypereosinophilic syndrome (HES) is a rare diagnosis defined by the World Health Organization as a persistent eosinophilia for 6 months and resulting in end-organ dysfunction. While many patients present with nonspecific symptoms, others will present with symptoms of the affected organs, most commonly those involving the heart, skin, or nervous system. Gastrointestinal or liver involvement is estimated to affect up to one-third of patients with HES, although patients with clinically significant disease are limited to case reports. This is the first report of a patient presenting with hepatitis and achalasia related to idiopathic HES.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gotlib J. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management. Am J Hematol. 2014;89(3):325–37. doi:10.1002/ajh.23664.

    Article  CAS  PubMed  Google Scholar 

  2. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med. 1982;97(1):78–92.

    Article  CAS  PubMed  Google Scholar 

  3. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83(10):2759–79.

    CAS  PubMed  Google Scholar 

  4. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54(1):1–27.

    Article  CAS  Google Scholar 

  5. Parrillo JE, Borer JS, Henry WL, Wolff SM, Fauci AS. The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med. 1979;67(4):572–82.

    Article  CAS  PubMed  Google Scholar 

  6. Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1985;102(1):109–14.

    Article  CAS  PubMed  Google Scholar 

  7. Kazmierowski JA, Chusid MJ, Parrillo JE, Fauci AS, Wolff SM. Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol. 1978;114(4):531–5.

    Article  CAS  PubMed  Google Scholar 

  8. Croffy B, Kopelman R, Kaplan M. Hypereosinophilic syndrome. Association with chronic active hepatitis. Dig Dis Sci. 1988;33(2):233–9.

    Article  CAS  PubMed  Google Scholar 

  9. Foong A, Scholes JV, Gleich GJ, Kephart GM, Holt PR. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome. Hepatology. 1991;13(6):1090–4.

    Article  CAS  PubMed  Google Scholar 

  10. Nagamura N, Ueno S, Fujishiro H, Oonuma H. Hepatitis associated with hypereosinophilia suspected to be caused by HES that also presented with the pathological features of IgG4-related disease. Intern Med. 2014;53(2):145–9.

    Article  PubMed  Google Scholar 

  11. Aoyama T, Matsumoto T, Uchiyama A, Kon K, Yamashina S, Suzuki S, et al. Recurrent severe acute hepatitis caused by hypereosinophilic syndrome associated with elevated serum immunoglobulin G4 levels. Clin J Gastroenterol. 2014;7(6):516–22. doi:10.1007/s12328-014-0532-0.

    Article  PubMed  Google Scholar 

  12. Man F, Chiocca JC. Achalasia due to eosinophil infiltration: fact or fiction? Dig Dis Sci. 1993;38(8):1561.

    Article  CAS  PubMed  Google Scholar 

  13. Goldblum JR, Whyte RI, Orringer MB, Appelman HD. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18(4):327–37.

    Article  CAS  PubMed  Google Scholar 

  14. Tøttrup A, Fredens K, Funch-Jensen P, Aggestrup S, Dahl R. Eosinophil infiltration in primary esophageal achalasia. A possible pathogenic role. Dig Dis Sci. 1989;34(12):1894–9.

    Article  PubMed  Google Scholar 

  15. Krill JT, Naik RD, Vaezi MF. Clinical management of achalasia: current state of the art. Clin Exp Gastroenterol. 2016;9:71–82. doi:10.2147/CEG.S84019.

    PubMed  PubMed Central  Google Scholar 

  16. Minami H, Inoue H, Haji A, Isomoto H, Urabe S, Hashiguchi K, et al. Per-oral endoscopic myotomy: emerging indications and evolving techniques. Dig Endosc. 2015;27(2):175–81. doi:10.1111/den.12328.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Financial disclosure: none to report. No individuals participated in the writing of this case report other than those listed as authors above.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amanda C. Cheung.

Ethics declarations

Conflict of Interest:

The authors have nothing to disclose.

Human/animal Rights:

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed Consent:

Informed consent was obtained from all patients for being included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheung, A.C., Hachem, C.Y. & Lai, J. Idiopathic hypereosinophilic syndrome presenting with hepatitis and achalasia. Clin J Gastroenterol 9, 238–242 (2016). https://doi.org/10.1007/s12328-016-0661-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-016-0661-8

Keywords

Navigation